These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9552393)

  • 1. DNA damage checkpoints: implications for cancer therapy.
    O'Connor PM; Fan S
    Prog Cell Cycle Res; 1996; 2():165-73. PubMed ID: 9552393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell cycle checkpoint function in bladder cancer.
    Doherty SC; McKeown SR; McKelvey-Martin V; Downes CS; Atala A; Yoo JJ; Simpson DA; Kaufmann WK
    J Natl Cancer Inst; 2003 Dec; 95(24):1859-68. PubMed ID: 14679155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cell cycle regulation after exposure to ionizing radiation].
    Teyssier F; Bay JO; Dionet C; Verrelle P
    Bull Cancer; 1999 Apr; 86(4):345-57. PubMed ID: 10341340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA damage and p53-mediated cell cycle arrest: a reevaluation.
    Pellegata NS; Antoniono RJ; Redpath JL; Stanbridge EJ
    Proc Natl Acad Sci U S A; 1996 Dec; 93(26):15209-14. PubMed ID: 8986789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Chk1-dependent G2 DNA damage checkpoint radiosensitizes p53 mutant human cells.
    Koniaras K; Cuddihy AR; Christopoulos H; Hogg A; O'Connell MJ
    Oncogene; 2001 Nov; 20(51):7453-63. PubMed ID: 11709716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining DNA damaging agents and checkpoint 1 inhibitors.
    Prudhomme M
    Curr Med Chem Anticancer Agents; 2004 Sep; 4(5):435-8. PubMed ID: 15379699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comprehensive complex systems approach to the study and analysis of mammalian cell cycle control system in the presence of DNA damage stress.
    Abroudi A; Samarasinghe S; Kulasiri D
    J Theor Biol; 2017 Sep; 429():204-228. PubMed ID: 28647496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of apoptosis and cell cycle-specific change in expression of p53 in normal lymphocytes and MOLT-4 leukemic cells by nitrogen mustard.
    Bhatia U; Danishefsky K; Traganos F; Darzynkiewicz Z
    Clin Cancer Res; 1995 Aug; 1(8):873-80. PubMed ID: 9816057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sterigmatocystin induces G1 arrest in primary human esophageal epithelial cells but induces G2 arrest in immortalized cells: key mechanistic differences in these two models.
    Wang J; Huang S; Xing L; Cui J; Tian Z; Shen H; Jiang X; Yan X; Wang J; Zhang X
    Arch Toxicol; 2015 Nov; 89(11):2015-25. PubMed ID: 25294323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell cycle checkpoints and DNA repair preserve the stability of the human genome.
    Kaufmann WK
    Cancer Metastasis Rev; 1995 Mar; 14(1):31-41. PubMed ID: 7606819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammalian G1 and G2 phase checkpoints.
    O'Connor PM
    Cancer Surv; 1997; 29():151-82. PubMed ID: 9338101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors of the G2 DNA damage checkpoint and their potential for cancer therapy.
    Anderson HJ; Andersen RJ; Roberge M
    Prog Cell Cycle Res; 2003; 5():423-30. PubMed ID: 14593736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular bases of the antitumor activity of a 7-substituted camptothecin in hormone-refractory human prostate carcinoma models.
    Zuco V; Supino R; De Cesare M; Carenini N; Perego P; Gatti L; Pratesi G; Pisano C; Martinelli R; Bucci F; Zanier R; Carminati P; Zunino F
    Biochem Pharmacol; 2003 Apr; 65(8):1281-94. PubMed ID: 12694869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the S and G2 checkpoint to treat cancer.
    Chen T; Stephens PA; Middleton FK; Curtin NJ
    Drug Discov Today; 2012 Mar; 17(5-6):194-202. PubMed ID: 22192883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UCN-01: a potent abrogator of G2 checkpoint function in cancer cells with disrupted p53.
    Wang Q; Fan S; Eastman A; Worland PJ; Sausville EA; O'Connor PM
    J Natl Cancer Inst; 1996 Jul; 88(14):956-65. PubMed ID: 8667426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular and cellular responses to DNA damage in a murine pituitary adenoma cell line.
    Woloschak M; Yu A; Xiao J
    Mol Cell Endocrinol; 1996 May; 119(1):61-8. PubMed ID: 8793854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell cycle checkpoint signaling: cell cycle arrest versus apoptosis.
    Pietenpol JA; Stewart ZA
    Toxicology; 2002 Dec; 181-182():475-81. PubMed ID: 12505356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuation of G1 checkpoint function by the non-genotoxic carcinogen phenobarbital.
    Gonzales AJ; Christensen JG; Preston RJ; Goldsworthy TL; Tlsty TD; Fox TR
    Carcinogenesis; 1998 Jul; 19(7):1173-83. PubMed ID: 9683175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell cycle checkpoints and their impact on anticancer therapeutic strategies.
    Eastman A
    J Cell Biochem; 2004 Feb; 91(2):223-31. PubMed ID: 14743382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA damage response following X-irradiation in oral cancer cell lines HSC3 and HSC4.
    Jiaranuchart S; Kaida A; Onozato Y; Harada H; Miura M
    Arch Oral Biol; 2018 Jun; 90():1-8. PubMed ID: 29522917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.